Ouster, Inc. (OUST)

NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-23

$29.69+6.11%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Ouster, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	61.89M
EPS	—	-0.045
Annual ending 2026-12-31
Revenue	—	221.4M
EPS	—	-0.285
Annual ending 2027-12-31
Revenue	—	297.81M
EPS	—	0.008

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Successful integration and growth from Stereolabs acquisition	A supporting condition in Ouster, Inc.'s published investment case. The stated target is Successful integration supporting revenue growth in next 4 quarters.	Improving	Acquisition fails to contribute to revenue growth or causes operational issues	Qualitative: Recent earnings beat (Aug 2026) and product launches support integration Earnings beat in Aug 2026, new lidar launches, but a May 2026 miss and $36B lawsuit threat. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Improvement toward profitability and positive free cash flow	A primary condition in Ouster, Inc.'s published investment case. The stated target is Reduce losses and improve free cash flow yield toward breakeven by FY27.	Improving	EPS and free cash flow do not improve toward breakeven by FY27	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue reaches $49.5M to $52.5M in 2026-Q2	A primary condition in Ouster, Inc.'s published investment case. The stated target is >= $49.5 million.	Intact	Revenue falls below $49.5 million in 2026-Q2	Revenue: $54.626M FY2026-Q2; GAAP. Published target: >= $49.5 million. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 6, 202654,626,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 6ada096c-667e-4d67-9efe-7ab2471f2202. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue$0.30B

$0.30B → $0.30B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$296,433,330	4 / 6
2026-07-25	Unavailable	$296,433,330	4 / 6
2026-07-26	Unavailable	$296,433,330	4 / 6
2026-07-27	Unavailable	$296,433,330	4 / 6
2026-07-28	Unavailable	$296,433,330	4 / 6
2026-07-29	Unavailable	$296,433,330	4 / 6
2026-07-30	Unavailable	$296,433,330	4 / 6
2026-07-31	Unavailable	Unavailable	3 / 4
2026-08-01	Unavailable	Unavailable	3 / 4
2026-08-02	Unavailable	$296,433,330	4 / 6
2026-08-03	Unavailable	$296,433,330	4 / 6
2026-08-04	Unavailable	Unavailable	3 / 4
2026-08-05	Unavailable	Unavailable	3 / 4
2026-08-06	Unavailable	$296,433,330	4 / 6
2026-08-07	Unavailable	Unavailable	3 / 4
2026-08-08	Unavailable	$296,433,330	4 / 6
2026-08-09	Unavailable	$296,433,330	4 / 6
2026-08-10	Unavailable	$296,433,330	4 / 6
2026-08-12	Unavailable	Unavailable	3 / 4
2026-08-13	Unavailable	Unavailable	3 / 4
2026-08-14	Unavailable	Unavailable	3 / 4
2026-08-15	Unavailable	Unavailable	3 / 4
2026-08-16	Unavailable	$297,971,429	3 / 5
2026-08-17	Unavailable	$297,971,429	3 / 5
2026-08-18	Unavailable	$297,971,429	3 / 5
2026-08-19	Unavailable	$297,971,429	3 / 5
2026-08-20	Unavailable	$297,814,286	3 / 5
2026-08-21	Unavailable	$297,814,286	3 / 5
2026-08-22	Unavailable	$297,814,286	3 / 5
2026-08-23	Unavailable	$297,814,286	3 / 5
2026-08-24	Unavailable	$297,814,286	3 / 5
2026-08-25	Unavailable	$297,814,286	3 / 5
2026-08-26	Unavailable	$297,814,286	3 / 5
2026-08-27	Unavailable	$297,814,286	3 / 5
2026-08-28	Unavailable	$297,814,286	3 / 5
2026-08-29	Unavailable	$297,814,286	3 / 5
2026-08-30	Unavailable	$297,814,286	3 / 5
2026-08-31	Unavailable	$297,814,286	3 / 5
2026-09-01	Unavailable	$297,814,286	3 / 5
2026-09-02	Unavailable	$297,814,286	3 / 5
2026-09-03	Unavailable	$297,814,286	3 / 5
2026-09-04	Unavailable	$297,814,286	3 / 5
2026-09-05	Unavailable	$297,814,286	3 / 5
2026-09-06	Unavailable	$297,814,286	3 / 5
2026-09-07	Unavailable	$297,814,286	3 / 5
2026-09-08	Unavailable	$297,814,286	3 / 5
2026-09-09	Unavailable	$297,814,286	3 / 5
2026-09-10	Unavailable	$297,814,286	3 / 5
2026-09-11	Unavailable	$297,814,286	3 / 5
2026-09-12	Unavailable	$297,814,286	3 / 5
2026-09-13	Unavailable	$297,814,286	3 / 5
2026-09-14	Unavailable	$297,814,286	3 / 5
2026-09-15	Unavailable	$297,814,286	3 / 5
2026-09-16	Unavailable	$297,814,286	3 / 5
2026-09-17	Unavailable	$297,814,286	3 / 5
2026-09-18	Unavailable	$297,814,286	3 / 5
2026-09-19	Unavailable	$297,814,286	3 / 5
2026-09-20	Unavailable	$297,814,286	3 / 5
2026-09-21	Unavailable	$297,814,286	3 / 5
2026-09-22	Unavailable	$297,814,286	3 / 5
2026-09-23	Unavailable	$297,814,286	3 / 5
2026-09-24	Unavailable	$297,814,286	3 / 5
2026-09-25	Unavailable	$297,814,286	3 / 5
2026-09-26	Unavailable	$297,814,286	3 / 5
2026-09-27	Unavailable	$297,814,286	3 / 5
2026-09-28	Unavailable	$297,814,286	3 / 5
2026-09-29	Unavailable	$297,814,286	3 / 5
2026-09-30	Unavailable	$297,814,286	3 / 5
2026-10-01	Unavailable	$297,814,286	3 / 5
2026-10-02	Unavailable	$297,814,286	3 / 5
2026-10-03	Unavailable	$297,814,286	3 / 5
2026-10-04	Unavailable	$297,814,286	3 / 5
2026-10-05	Unavailable	$297,814,286	3 / 5
2026-10-06	Unavailable	$297,814,286	3 / 5
2026-10-07	Unavailable	$297,814,286	3 / 5
2026-10-08	Unavailable	$297,814,286	3 / 5
2026-10-09	Unavailable	$297,814,286	3 / 5
2026-10-10	Unavailable	$297,814,286	3 / 5
2026-10-11	Unavailable	$297,814,286	3 / 5
2026-10-12	Unavailable	$297,814,286	3 / 5
2026-10-13	Unavailable	$297,814,286	3 / 5
2026-10-14	Unavailable	$297,814,286	3 / 5
2026-10-15	Unavailable	$297,814,286	3 / 5
2026-10-16	Unavailable	$297,814,286	3 / 5
2026-10-17	Unavailable	$297,814,286	3 / 5
2026-10-18	Unavailable	$297,814,286	3 / 5
2026-10-19	Unavailable	$297,814,286	3 / 5
2026-10-20	Unavailable	$297,814,286	3 / 5
2026-10-21	Unavailable	$297,814,286	3 / 5
2026-10-22	Unavailable	$297,814,286	3 / 5
2026-10-23	Unavailable	$297,814,286	3 / 5
2026-10-24	Unavailable	$297,814,286	3 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	6	1
2026-06-01	6	1
2026-07-01	6	1
2026-08-01	6	1
2026-09-01	6	1
2026-10-01	5	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 5 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Improvement toward profitability and positive free cash flowDirect metric needs a verified mapping
Revenue reaches $49.5M to $52.5M in 2026-Q2Revenue: $54.626M

Next proof point

Nov 3, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

4.9%Typical daily move · historical

Downside history

-55.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Ouster, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a high-risk growth business, not a proven durable compounder, because it remains loss-making. The long-term thesis is in a watch state: recent growth and product progress support it, while performance below its industry cohort and a shift in the signal to mixed weigh on it.

What's priced into Ouster, Inc.

The valuation is at a substantial premium to peers, which suggests the market already assigns value to durable growth. The expectations gap is close to neutral, but confidence in that reading is low, so the premium may leave limited room for execution setbacks.

What the fundamentals likely do

Near term, revenue and shipments grew from the first to the second quarter of 2026, and management says Rev8 OS commercialization and Stereolabs integration are on track. However, the business remains loss-making, recent performance is weak relative to its industry cohort, and earnings surprises have been erratic and trending down; a guidance cut would be a meaningful negative.

What Ouster, Inc. hinges on

Over the next several quarters, the thesis hinges on sustaining revenue growth, increasing shipments, and turning Rev8 OS and Stereolabs progress into measurable commercial results. Near-term conditions could also be helped by lower interest rates and continued strength from major technology companies, while weaker guidance or execution would challenge the growth case.